Press Room

News / May 13, 2021

Hovione Virtual Run

The biggest race in Loures - Portugal is back and it's virtual!

The Hovione Run is back, in virtual format! The biggest race in Loures/ Portugal, this year goes global and will have national and international participants.

Between the 4th, 5th and 6th of June, athletes will be able to travel one of the three distances available:

Virtual Run | Hovione

Registration is completely free.

REGISTER HERE

 

AWARDS

  • Virtual finisher medal
  • Diploma to be consulted in the results menu of the website www.xistarca.pt *
  • Virtual cup for the top 3 male and female runners from each distance

* At the end of the race, you must answer a questionnaire, which will be sent to all registered participants and which will also be available on this page, indicating the race time and a photo that proves the same.

 

CLASSIFICATIONS

The general classification will be published on the event’s website, taking as correct the information that will be sent to the organization, not being approved for competitive purposes.

 

Learn more at www.xistarca.pt

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025